Finerenone

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 961 publications

Nephrology: What You May Have Missed in 2025.

Nephrology: What You May Have Missed in 2025.

Journal: Annals of internal medicine
Published: April 13, 2026

Endocrinology: What You May Have Missed in 2025.

Endocrinology: What You May Have Missed in 2025.

Journal: Annals of internal medicine
Published: April 13, 2026

Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical Trial.

Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical Trial.

Journal: JAMA cardiology
Published: March 28, 2026

EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HF.

EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HF.

Journal: JAMA cardiology
Published: March 28, 2026

Sexual Dimorphism and Age Effects in CKD and Type 2 Diabetes in the CONFIDENCE Trial.

Sexual Dimorphism and Age Effects in CKD and Type 2 Diabetes in the CONFIDENCE Trial.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: March 27, 2026

Finerenone, New-Onset Atrial Fibrillation, and Prognosis in HFpEF/HFmrEF-Reply.

Finerenone, New-Onset Atrial Fibrillation, and Prognosis in HFpEF/HFmrEF-Reply.

Journal: JAMA cardiology
Published: March 25, 2026

Finerenone, New-Onset Atrial Fibrillation, and Prognosis in HFpEF/HFmrEF.

Finerenone, New-Onset Atrial Fibrillation, and Prognosis in HFpEF/HFmrEF.

Journal: JAMA cardiology
Published: March 25, 2026

Can we differentiate between finerenone, eplerenone and spironolactone in HFmrEF/HFpEF through a Bayesian lens?

Can we differentiate between finerenone, eplerenone and spironolactone in HFmrEF/HFpEF through a Bayesian lens?

Journal: European journal of heart failure
Published: March 22, 2026

Reductions in Myocardial Interstitial Fibrosis are Dissociated From LV Chamber Stiffness in Swine with Repetitive Pressure Overload.

Reductions in Myocardial Interstitial Fibrosis are Dissociated From LV Chamber Stiffness in Swine with Repetitive Pressure Overload.

Journal: American journal of physiology. Heart and circulatory physiology
Published: March 12, 2026

Finerenone in HFmrEF and HFpEF: Modest Gains in Patient Quality of Life.

Finerenone in HFmrEF and HFpEF: Modest Gains in Patient Quality of Life.

Journal: European journal of heart failure
Published: March 09, 2026

Combination Therapy with Finerenone and Sodium-Glucose Cotransporter Inhibitors: Who, When, How?

Combination Therapy with Finerenone and Sodium-Glucose Cotransporter Inhibitors: Who, When, How?

Journal: Journal of the American Society of Nephrology : JASN
Published: March 05, 2026

Cardioprotective Effects of Finerenone Associated With the Suppression of Myocardial Sodium Accumulation in Aldosterone/Salt-Loaded Rats.

Cardioprotective Effects of Finerenone Associated With the Suppression of Myocardial Sodium Accumulation in Aldosterone/Salt-Loaded Rats.

Journal: Journal of the American Heart Association
Published: March 04, 2026
Showing 1-12 of 961

Last Updated: 04/28/2026